adequada ao corticosteroide, pode-se associar azatioprina ou ciclosporina 206 . Um dos principais fatores determinantes da recorrência é a redução rápida da dose de corticoide, que não deve ser feita num período inferior a três meses. A pericardiectomia está indicada para os casos com recorrência frequente, muito sintomática e refratária à terapêutica 333-335 . A tabela 37 resume as indicações para o tratamento na pericardite recorrente. I Diretriz Brasileira de Miocardites e Pericardites Diretrizes Tabela 37 – Indicações para o tratamento da pericardite recorrente. Classe de recomendação Classe I Classe IIa Classe IIa Classe IIb Classe IIb Classe IIb Indicações Colchicina por 6 meses no tratamento da pericardite recorrente Asprina ou ibuprofeno para o tratamento da pericardite recorrente Colchicina para o tratamento de pericardite pós infarto agudo do miocárdio Pericardiectomia no tratamento de pericardite recorrente para casos refratários e muito sintomáticos Corticosteroides sistêmicos no tratamento da pericardite recorrente após falha no tratamento com AINEs e colchicina Utilização de outros agentes imunossupressores (azatioprina e ciclosporina) nas recorrências por doenças auto-imunes ou do colágeno Nível de evidência Arq Bras Cardiol: 2013; 100(4 Supl. 1): 1-36 B B B B C C 27
28 I Diretriz Brasileira de Miocardites e Pericardites Diretrizes Referências 1. Carniel E, Sinagra G, Bussani R, Di Lenarda A, Pinamonti B, Lardieri G, et al. Fatal myocarditis: morphologic and clinical features. Ital Heart J. 2004;5(9):702-6. 2. Kytö V, Saraste A, Voipio-Pulkki LM, Saukko P. Incidence of fatal myocarditis: a population-based study in Finland. Am J Epidemiol. 2007;165(5):570-4. 3. Hahn EA, Hartz VL, Moon TE, O’Connell JB, Herskowitz A, McManus BM, et al. The Myocarditis Treatment Trial: design, methods and patients enrollment. Eur Heart J. 1995;16 (Suppl O):162-7. 4. Kühl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with “idiopathic” left ventricular dysfunction. Circulation. 2005;111(7):887-93. 5. Neuspiel DR, Kuller LH. Sudden and unexpected natural death in childhood and adolescence. JAMA. 1985;254(10):1321-5. 6. Rahman JE, Helou EF, Gelzer-Bell R, Thompson RE, Kuo C, Rodriguez ER, et al. Noninvasive diagnosis of biopsy- proven cardiac amyloidosis. J Am Coll Cardiol. 2004;43(3):410-5. 7. Frustaci A, Verardo R, Caldarulo M, Acconcia MC, Russo MA, Chimenti C. Myocarditis in hypertrophic cardiomyopathy patients presenting acute clinical deterioration. Eur Heart J. 2007;28(6):733-40. 8. JCS Joint Working Group. Guidelines for diagnosis and treatment of myocarditis (JCS 2009): digest version. Circ J. 2011;75(3):734-43. 9. Montera MW, Pereira Y, Silva EL, Takiya C, Mesquita ET. Accuracy of non invasive methods to diagnose Chronic Myocarditis in patients with dilated cardiomyophaty. Eur J Heart Fail. 2011;. S10: S162–S165. 10. Blauwet LA, Cooper LT. Myocarditis. Prog Cardiovasc Dis. 2010;52(4):274-88. 11. McAlister HF, Klementowicz PT, Andrews C, Fisher JD, Feld M, Furman S. Lyme carditis: an important cause of reversible heart block. Ann Intern Med. 1989;110(5):339-45. 12. Andrade JP, Marin-Neto JA, Paola AA, Vilas-Boas F, Oliveira GM, Bacal F, et al; Sociedade Brasileira de Cardiologia. I Diretriz Latino Americana para o diagnóstico e tratamento da cardiopatia chagásica. Arq Bras Cardiol. 2011;97(2 supl. 3):1-47. 13. Kilian JG, Kerr K, Lawrence C, Celermajer DS. Myocarditis and cardiomyopathy associated with clozapine. Lancet. 1999;354(9193):1841-5. 14. Stelts S, Taylor MH, Nappi J, Van Bakel AB. Mesalamine associated hypersensitivity myocarditis in ulcerative colitis. Ann Pharmacother. 2008;42(6):904-5. 15. Murphy JG, Wright RS, Bruce GK, Baddour LM, Farrell MA, Edwards WD, et al. Eosinophilic-lymphocytic myocarditis after smallpox vaccination. Lancet. 2003;362(9393):1378-80. 16. Cassimatis DC, Atwood JE, Engler RM, Linz PE, Grabenstein JD, Vernalis MN. Smallpox vaccination and myopericarditis: a clinical review. J Am Coll Cardiol. 2004;43(9):1503-10. 17. Corssmit EP, Trip MD, Durrer JD. Loeffler’s endomyocarditis in the idiopathic hypereosinophilic syndrome. Cardiology. 1999;91(4):272-6. 18. Nunes H, Freynet O, Naggara N, Soussan M, Weinman P, Diebold B, et al. Cardiac sarcoidosis. Semin Respir Crit Care Med. 2010;31(4):428-41. 19. Cooper LT Jr. Giant cell and granulomatous myocarditis. Heart Fail Clin. 2005;1(3):431-7. 20. Felker GM, Jaeger CJ, Klodas E, Thiemann DR, Hare JM, Hruban RH, et al. Myocarditis and long-term survival in peripartum cardiomyopathy. Am Heart J. 2000;140(5):785-91. 21. Midei MG, <strong>De</strong>Ment SH, Feldman AM, Hutchins GM, Baughman KL. Peripartum myocarditis and cardiomyopathy. Circulation. 1990;81(3):922-8. 22. Kindermann I, Barth C, Mahfoud F, Ukena C, Lenski M, Yilmaz A, et al. Update on myocarditis. J Am Coll Cardiol. 2012;59(9):779-92. Arq Bras Cardiol: 2013; 100(4 Supl. 1): 1-36 23. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation. 1999;99(8):1091-100. 24. Yuen S, Smith J, Caruso L, Balan M, Opavsky MA. The coxsackie-adenovirus receptor induces an inflammatory cardiomyopathy independent of viral infection. J Mol Cell Cardiol. 2011;50(5):826-40. 25. Oakley CM. Myocarditis, pericarditis and other pericardial diseases. Heart. 2000;84(4):449-54. 26. Ammann P, Naegeli B, Schuiki E, Straumann E, Frielingsdorf J, Rickli H, et al. Long-term outcome of acute myocarditis is independent of cardiac enzyme release. Int J Cardiol. 2003;89(2-3):217-22. 27. Mason JW. Myocarditis. Adv Intern Med. 1999;44:293-310. 28. Andréoletti L, Lévêque N, Boulagnon C, Brasselet C, Fornes P. Viral causes of human myocarditis. Arch Cardiovasc Dis. 2009;102(6-7):559-68. 29. Cooper LT Jr. Myocarditis. N Engl J Med. 2009;360(15):1526-38. 30. Taliercio CP, Olney BA, Lie JT. Myocarditis related to drug hypersensitivity. Mayo Clin Proc. 1985;60(7):463-8. 31. Arness MK, Eckart RE, Love SS, Atwood JE, Wells TS, Engler RJ, et al. Myopericarditis following smallpox vaccination. Am J Epidemiol. 2004;160(7):642-51. 32. Spodick DH. Eosinophilic myocarditis. Mayo Clin Proc. 1997;72(10):996. 33. Narula N, McNamara DM. Endomyocardial biopsy and natural history of myocarditis. Heart Fail Clin. 2005;1(3):391-406. 34. Rosenstein ED, Zucker MJ, Kramer N. Giant cell myocarditis: most fatal of autoimmune diseases. Semin Arthritis Rheum. 2000;30(1):1-16. 35. Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet. 2003;361(9363):1111-8. 36. Thomas PD, Hunninghake GW. Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis. 1987;135(3):747-60. 37. Caforio AL, Calabrese F, Angelini A, Tona F, Vinci A, Bottaro S, et al. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J. 2007;28(11):1326-33. 38. Montera MW, Karinina A, Lycurgo G, Silva EE, Takya C, Evandro T, et al. Clinical and functional profile of patients with viral miocarditis vs non viral miocarditis. J Card Fail. 2006;12(6 Suppl):S28. 39. Magnani JW, <strong>De</strong>c GW. Myocarditis: current trends in diagnosis and treatment. Circulation. 2006;113(6):876-90. 40. <strong>De</strong>c GW Jr, Palacios IF, Fallon JT, Aretz HT, Mills J, Lee DC, et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies: clinical features, histologic correlates, and clinical outcome. N Engl J Med. 1985;312(14):885-90. 41. Amabile NF, Fraisse A, Bouvenot J, Chetaille P, Ovaert C. Outcome of acute fulminant myocarditis in children. Heart. 2006;92(9):1269-73. 42. Morimoto S, Kato S, Hiramitsu S, Uemura A, Ohtsuki M, Kato Y, et al. Role of myocardial interstitial edema in conduction disturbances in acute myocarditis. Heart Vessels. 2006;21(6):356-60. 43. Yazaki Y, Isobe M, Hiramitsu S, Morimoto S, Hiroe M, Omichi C, et al. Comparison of clinical features and prognosis of cardiac sarcoidosis and idiopathic dilated cardiomyopathy. Am J Cardiol. 1998;82(4):537-40. 44. Mahfoud F, Gärtner B, Kindermann M, Ukena C, Gadomski K, Klingel K, et al. Virus serology in patients with suspected myocarditis: utility or futility? Eur Heart J. 2011;32(7):897-903. 45. Morgera T, Di Lenarda A, Dreas L, Pinamonti B, Humar F, Bussani R, et al. Electrocardiography of myocarditis revisited: clinical and prognostic significance of electrocardiographic changes. Am Heart J. 1992;124(2):455-67.